2024
The early COVID-19 pandemic period and associated gestational weight gain
Madein A, Lundsberg L, Culhane J, Partridge C, Son M, Merriam A. The early COVID-19 pandemic period and associated gestational weight gain. Journal Of Perinatal Medicine 2024, 0 PMID: 39485230, DOI: 10.1515/jpm-2024-0088.Peer-Reviewed Original ResearchGestational weight gainGestational ageWeight gainAssociated with weight gainInstitute of MedicineMaternal weight gainWeight gain riskRetrospective cohort studyInstitute of Medicine recommendationsTertiary care hospitalNo significant differenceEarly pandemic periodCohort studyPrimary outcomeMedical record dataCare hospitalPandemic groupPandemic epochSignificant differenceLogistic regressionElectronic medical record dataExposure groupMultinominal logistic regressionPandemic periodAgeLidocaine Patches After Cesarean Sections: A Randomized Control Trial
Arkfeld C, Starosta A, Esencan E, Athens Z, Lundsberg L, Merriam A. Lidocaine Patches After Cesarean Sections: A Randomized Control Trial. American Journal Of Obstetrics & Gynecology MFM 2024, 101536. PMID: 39491590, DOI: 10.1016/j.ajogmf.2024.101536.Peer-Reviewed Original ResearchPost-operative pain scoresLidocaine patch groupVisual analog scalePost-operative day 1Pain scoresLidocaine patchCesarean sectionAnalog scalePatch groupDay 1Post-cesarean pain managementPost-operative hospital stayVisual analog pain scoreDay 3Day 2Day 4Controlled trialsControlled trials of patientsAnalog pain scoresBaseline maternal characteristicsTrial of patientsOpiate use disorderPain management strategiesPost-operative periodAbdominal hernia repairDesign, rationale and protocol for Glycemic Observation and Metabolic Outcomes in Mothers and Offspring (GO MOMs): an observational cohort study
Group T, Scholtens D, LeBlanc E, Vesco K, Amy D, Bays K, Massimino S, Robinson S, Schell K, Walters G, Hillier T, Oshiro C, Cordero S, Howick C, Kim L, Martinez Y, Pishchalenko O, Wastlova V, Zork N, Mourad M, Lonier J, Reddy U, Acevedo J, Castillo J, Gomez M, Peguero B, Facco F, Feghali M, Bocan H, Stramowski S, Powe C, Edlow A, Barth W, Nathan D, Azevedo R, Baez A, Iroajanma C, Larkin M, Maya J, Michalopoulos C, Neamonitaki N, Thangthaeng N, Yee L, Lowe W, Grobman W, Szmuilowicz E, Aguirre A, Guevara E, Mallett G, Matos S, Tyagi S, Spadola A, Catalano P, Azimirad A, Werner E, Rouse D, Malloy M, Parra F, Sherr J, Merriam A, Bitterman S, Considine E, Leventhal J, Perley L, Rink L, Steffen A, Thompson B, Zgorski M, Steffes M, Arends V, Killeen A, Siddique J, Bustamante P, Cheung Y, Freeze C, Grott T, Kuang A, Tull M, Linder B. Design, rationale and protocol for Glycemic Observation and Metabolic Outcomes in Mothers and Offspring (GO MOMs): an observational cohort study. BMJ Open 2024, 14: e084216. PMID: 38851233, PMCID: PMC11163666, DOI: 10.1136/bmjopen-2024-084216.Peer-Reviewed Original ResearchConceptsLarge-for-gestational-age birth weightMetabolic outcomesLarge-for-gestational-ageDiagnosis of gestational diabetesOral glucose tolerance testAdverse pregnancy outcomesVanderbilt University Institutional Review BoardCourse of pregnancyObservational cohort studyGlucose tolerance testNational Institute of DiabetesDigestive and Kidney DiseasesGDM treatmentWeeks gestationDetect such abnormalitiesPerinatal outcomesGDM screeningInstitutional review boardGestational diabetesFirst-trimesterPregnancy outcomesEarly pregnancyGlucose abnormalitiesBirth weightPregnant adultsFor Patients Undergoing an Induction of Labor, Does Increased Body Mass Index Necessitate Higher Doses of Misoprostol? [ID 2683640]
Mason-Otey A, Lundsberg L, Culhane J, Merriam A. For Patients Undergoing an Induction of Labor, Does Increased Body Mass Index Necessitate Higher Doses of Misoprostol? [ID 2683640]. Obstetrics And Gynecology 2024, 143: 46s-46s. DOI: 10.1097/01.aog.0001013576.14925.24.Peer-Reviewed Original ResearchInduction of laborBody mass indexBody mass index categoriesDose of misoprostolMisoprostol doseClass IIIMass indexProlonged induction of laborClass IIAssociated with increased BMIClass IIncreased BMIPre-gestational diabetesClass II obesityClass I obesityRetrospective cohort analysisMisoprostol administrationObese patientsII obesityMisoprostolInvestigate safetyHigh dosesPrimary outcomeCohort analysisPatientsAbsence of Adverse Maternal and Neonatal Outcomes in Patients with 1 or 2 Abnormal Values During Early Glucose Tolerance Testing
Geng B, Lundsberg L, Culhane J, Merriam A. Absence of Adverse Maternal and Neonatal Outcomes in Patients with 1 or 2 Abnormal Values During Early Glucose Tolerance Testing. American Journal Of Obstetrics And Gynecology 2024, 230: e103-e107. PMID: 38242338, DOI: 10.1016/j.ajog.2024.01.007.Peer-Reviewed Original Research284 Postpartum diabetes screening rates and 1-year outcomes for individuals with early onset gestational diabetes
Pifer B, Geng B, Lundsberg L, Culhane J, Partridge C, Merriam A. 284 Postpartum diabetes screening rates and 1-year outcomes for individuals with early onset gestational diabetes. American Journal Of Obstetrics And Gynecology 2024, 230: s163-s164. DOI: 10.1016/j.ajog.2023.11.306.Peer-Reviewed Original Research
2023
Reply: The Risk Factor for Maternal Morbidity is Racism, Not Race
Merriam A, Metz T, Allshouse A, Silver R, Haas D, Grobman W, Simhan H, Wapner R, Wing D, Mercer B, Parry S, Reddy U, investigators N. Reply: The Risk Factor for Maternal Morbidity is Racism, Not Race. American Journal Of Perinatology 2023, 41: e3274-e3275. PMID: 37863072, DOI: 10.1055/a-2195-6914.Peer-Reviewed Original ResearchStructural racismSystemic racismRacismSocial constructRacial categoriesSocial determinantsEffect of raceRacial groupsRaceMaternal health outcomesAuthor’s pointWhite participantsImplicit biasDiscussionAsiansHealth careInequitiesResearch publicationsCritical concernConcernHealth outcomesUnderlying reasonsThromboembolic Disorders
Merriam A, Pettker C. Thromboembolic Disorders. 2023, 123-133. DOI: 10.1002/9781119636540.ch15.Peer-Reviewed Original ResearchVenous thromboembolismPulmonary embolismLeading causeDeep venous thrombosisCommon physical symptomsOperative vaginal deliveryPregnancy-specific risk factorsMaternal morbidityCesarean deliveryMultiple gestationsMaternal deathsVaginal deliveryVenous thrombosisPostpartum hemorrhageMaternal mortalityNonpregnant individualsThrombotic riskPostpartum periodRisk factorsThromboembolic disordersLow prevalencePhysical symptomsPregnancySymptomsThromboembolismCollaboration between maternal-fetal medicine and family planning: a survey of Northeast US academic medical centers
Merriam A, Lundsberg L, Cutler A, Maxam T, Paul M. Collaboration between maternal-fetal medicine and family planning: a survey of Northeast US academic medical centers. Journal Of Perinatal Medicine 2023, 52: 81-89. PMID: 37853776, DOI: 10.1515/jpm-2023-0118.Peer-Reviewed Original ResearchConceptsMaternal-fetal medicineAcademic medical centerMedical CenterAbortion carePatient careFamily planningUS academic medical centersPatient care teamOptimal patient careCross-sectional online surveyPractice patternsCare teamResponse rateBivariate analysisPractice locationCareDemographic informationImproved educationAbortion servicesAbortion accessFindings highlight areasOne-thirdLikert scale questionsMedicineHighlight areasNavigating Infertility When Practicing Obstetrics
Merriam A. Navigating Infertility When Practicing Obstetrics. Obstetrics And Gynecology 2023, 142: 1255-1257. PMID: 37708517, DOI: 10.1097/aog.0000000000005350.Peer-Reviewed Original ResearchLow-Dose Aspirin during Pregnancy and Postpartum Bleeding
White K, Son M, Lundsberg L, Culhane J, Partridge C, Reddy U, Merriam A. Low-Dose Aspirin during Pregnancy and Postpartum Bleeding. American Journal Of Perinatology 2023, 40: 1390-1397. PMID: 37211010, DOI: 10.1055/a-2096-5199.Peer-Reviewed Original ResearchConceptsLow-dose aspirinPostpartum blood lossTiming of discontinuationBlood lossPostpartum bleedingPostpartum hemorrhageLDA useUse of LDARed blood cell transfusionBlood cell transfusionRetrospective cohort studySystemic lupus erythematosusTime of deliveryDiagnosis of diabetesLogistic regression modelingElectronic medical recordsAspirin 81Ideal dosingPreeclampsia preventionCell transfusionDose aspirinCohort studyHypertensive diseaseLupus erythematosusPrimary outcomeMaternal Morbidity Risk Factors in Nulliparas
Merriam A, Metz T, Allshouse A, Silver R, Haas D, Grobman W, Simhan H, Wapner R, Wing D, Mercer B, Parry S, Reddy U, Investigators +. Maternal Morbidity Risk Factors in Nulliparas. American Journal Of Perinatology 2023, 41: e1878-e1884. PMID: 37150178, DOI: 10.1055/a-2088-2586.Peer-Reviewed Original ResearchVenous thromboembolic eventsSelf-identified black raceComposite maternal morbidityPrimary maternal outcomeSevere maternal morbidityMaternal morbidityChronic kidney diseaseBlack raceRisk factorsChronic hypertensionHypertensive disordersMaternal outcomesPregestational diabetesKidney diseaseMedical conditionsMulticenter prospective observational cohortPrepregnancy body mass indexPreexisting medical comorbiditiesPrior obstetric historyProspective observational cohortMorbidity risk factorsBody mass indexMultiple risk factorsDays of deliveryLog-binomial regressionAttitudes of Maternal Fetal Medicine specialists on prenatal diagnosis, disability and termination
Sallam A, Gazzola M, Merriam A, Mercurio M, Drago M. Attitudes of Maternal Fetal Medicine specialists on prenatal diagnosis, disability and termination. SSM - Qualitative Research In Health 2023, 3: 100232. DOI: 10.1016/j.ssmqr.2023.100232.Peer-Reviewed Original ResearchSelf-Efficacy and Outcomes in Women with Diabetes: A Prospective Comparative Study
Doughty K, Abeyaratne D, Merriam A, Taylor S. Self-Efficacy and Outcomes in Women with Diabetes: A Prospective Comparative Study. Breastfeeding Medicine 2023, 18: 307-314. PMID: 36999939, PMCID: PMC10124167, DOI: 10.1089/bfm.2022.0298.Peer-Reviewed Original ResearchConceptsExclusive breastfeedingDiabetes statusHospital dischargeBreastfeeding outcomesBreastfeeding intentionNeonatal intensive care unit admissionIntensive care unit admissionOwn breastfeeding goalsCare unit admissionHospital-related factorsProspective comparative studyType of diabetesElectronic medical recordsEarly breastfeeding outcomesInfant hypoglycemiaNeonatal complicationsNICU admissionUnit admissionBirth hospitalizationDiabetic mothersEBF ratesWeeks' gestationBreastfeeding goalsWeeks postbirthWeeks postpartumSevere Maternal Morbidity Review and Preventability Assessment in a Large Academic Center
Grechukhina O, Lipkind H, Lundsberg L, Merriam A, Raab C, Leon-Martinez D, Campbell K. Severe Maternal Morbidity Review and Preventability Assessment in a Large Academic Center. Obstetrics And Gynecology 2023, 141: 857-860. PMID: 36897178, DOI: 10.1097/aog.0000000000005116.Peer-Reviewed Original ResearchConceptsSevere maternal morbiditySystem-level factorsYale-New Haven HospitalRetrospective cohort studyHealth careDetailed case reviewLarge academic centerSMM ratesMaternal morbidityCohort studyPreventability assessmentPreventable causeSMM casesMorbidity reviewAmerican CollegeAcademic centersConsensus criteriaCase reviewPractice changeCareCauseMorbidityHemorrhagePreventabilityReviewEvaluating the relationship between early glucose tolerance test screening and adverse neonatal and maternal outcomes
Geng B, Lundsberg L, Culhane J, Merriam A. Evaluating the relationship between early glucose tolerance test screening and adverse neonatal and maternal outcomes. American Journal Of Obstetrics And Gynecology 2023, 228: s441-s442. DOI: 10.1016/j.ajog.2022.11.764.Peer-Reviewed Original Research
2022
Does Antenatal Progesterone Administration Modify the Risk of Neonatal Intraventricular Hemorrhage?
Leon-Martinez D, Bank TC, Lundsberg LS, Culhane J, Silasi M, Son M, Partridge C, Reddy UM, Hoffman MK, Merriam A. Does Antenatal Progesterone Administration Modify the Risk of Neonatal Intraventricular Hemorrhage? American Journal Of Perinatology 2022, 41: e46-e52. PMID: 35436803, DOI: 10.1055/a-1827-6712.Peer-Reviewed Original ResearchNeonatal intraventricular hemorrhageIntraventricular hemorrhageBrain injuryOdds ratioDiagnosis of IVHRisk of IVHImproved neurological outcomeNeonatal brain injuryLarge academic medical centerConfidence intervalsRoute of deliveryEffect of progesteroneTraumatic brain injuryAcademic medical centerHospitalization encountersNeurological outcomePreterm neonatesSingleton deliveriesMaternal administrationProgesterone administrationRetrospective studyAntepartum periodLow birthweightPotential confoundersDiagnosis codesPerformance of a Multianalyte ‘Rule-Out’ Assay in Pregnant Individuals With Suspected Preeclampsia
Costantine MM, Sibai B, Bombard AT, Sarno M, West H, Haas DM, Tita AT, Paidas MJ, Clark EAS, Boggess K, Grotegut C, Grobman W, Su EJ, Burd I, Saade G, Chavez MR, Paglia MJ, Merriam A, Torres C, Habli M, Macones G, Wen T, Bofill J, Palatnik A, Edwards RK, Haeri S, Oberoi P, Mazloom A, Cooper M, Lockton S, Hankins GD. Performance of a Multianalyte ‘Rule-Out’ Assay in Pregnant Individuals With Suspected Preeclampsia. Hypertension 2022, 79: 1515-1524. PMID: 35545947, PMCID: PMC9172903, DOI: 10.1161/hypertensionaha.122.19038.Peer-Reviewed Original ResearchConceptsDays of enrollmentPregnant individualsStudy cohortNegative predictive value 95.0Multivariate Cox regression modelHigh negative predictive valueMulticenter cohort studyIncidence of preeclampsiaCox regression modelTime of enrollmentNegative predictive valueNegative control groupNegative likelihood ratioCohort studyPreeclampsiaBaseline evaluationPrimary analysisControl groupPredictive valueWeeksModerate sensitivityCohortEnrollmentLikelihood ratioRegression modelsPlacenta accreta spectrum: clinical and sonographic characteristics associated with predictive ability
Greenberg V, Lundsberg L, Kohari K, Merriam A. Placenta accreta spectrum: clinical and sonographic characteristics associated with predictive ability. American Journal Of Obstetrics And Gynecology 2022, 226: s586. DOI: 10.1016/j.ajog.2021.11.968.Peer-Reviewed Original Research
2021
888 Markers of maternal morbidity in nulliparous women
Merriam A, Allshouse A, Metz T, Silver R, Haas D, Grobman W, Wapner R, Wing D, Mercer B, Reddy U. 888 Markers of maternal morbidity in nulliparous women. American Journal Of Obstetrics And Gynecology 2021, 224: s551. DOI: 10.1016/j.ajog.2020.12.911.Peer-Reviewed Original Research